The global Single Photon Emission Computed Tomography (SPECT) market is forecasted to grow from USD 3.2 billion in 2024 to approximately USD 6.1 billion by 2034, at a CAGR of 6.6%. Key drivers include the increasing demand for precise diagnostic tools, advancements in imaging technology, and a rising global burden of chronic diseases. SPECT is especially critical in cardiology and neurology for early disease detection and treatment planning. However, U.S. tariffs on imported medical equipment are causing financial strain on manufacturers and healthcare providers, leading to higher costs and potential delays in equipment upgrades, which could adversely affect patient care. The portable SPECT segment is thriving, representing a 47.6% market share in 2023 due to growing demand for mobile diagnostic tools. The oncology segment is also expanding rapidly, capturing 49.3% of market revenue, driven by a rise in cancer diagnoses. North America currently dominates the SPECT market, but the Asia Pacific region is expected to experience the highest growth, supported by government policies and a rising elderly population. Overall, SPECT is anticipated to remain a vital tool for enhancing patient outcomes and driving advancements in diagnostic imaging as healthcare systems increasingly rely on advanced technologies.
Mon, 26 May 2025 11:15:38 GMT | Market.us Media